During the past decade, UAB Advanced Imaging Facility conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "UAB Advanced Imaging Facility" are "Hepatocellular Carcinoma" (1 trials), "Metastatic Colon Cancer" (1 trials), "Parkinson Disease" (1 trials), "Pediatric Brain Tumors" (1 trials) and "Validation of a New Noninvasive Method to Obtain the Arterial Input Function (AIF) Directly by PET Imaging" (1 trials). Many other conditions were trialed in "UAB Advanced Imaging Facility" in a lesser frequency.

Most popular intervention types in "UAB Advanced Imaging Facility" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Acetazolamide" (1 trials), "DPA-714-PET/MRI" (1 trials), "FET PET/MRI" (1 trials), "FMISO" (1 trials) and "[89Zr]Panitumumab PET-MRI" (1 trials). Other intervention names were less common.

The vast majority of trials in "UAB Advanced Imaging Facility" are 5 trials for "All" genders.

Currently, there are NaN active trials in "UAB Advanced Imaging Facility". 1 are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in UAB Advanced Imaging Facility, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in UAB Advanced Imaging Facility, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".